SALVADOR APARISI ALEPUZ

Salvador Aparisi Alepuz is a researcher in the Department of Physiology, affiliated with the Universitat de València, where he completed his doctoral studies in 2022. His research focuses on the molecular mechanisms underlying resistance to targeted therapies in lung cancer.

Research Interests: His work primarily investigates the role of endothelin-1 and intratumoral hypoxia in mediating resistance to EGFR-targeted therapies. This places his expertise at the intersection of cancer biology, molecular signaling, and physiological tumor microenvironment dynamics.

No recent publications are listed in the provided text, so trends in publication output cannot be assessed at this time.

Scientific Awards: No awards or honors are mentioned in the available information.

Advising and Grants: While Salvador was supervised during his doctoral work by Dr. Julián Carretero Asunción, Dr. Javier Pereda Cervera, and Dr. Agustín Lahoz Rodríguez, there is no indication of students he has advised or grants he has led.

Labs and Research Teams: He is associated with a research group focused on cancer physiology and targeted therapy resistance, likely within the broader biomedical research structure of the Universitat de València, though specific lab or team names are not provided.